Since our research indicates that BART13-3p changes the biological behaviors of NPC cells and promotes their malignant characterization through c-JUN/SLUG signaling, targeting which may be a new therapeutic strategy for NPC. Here, SNAI2 is linked to nasopharyngeal carcinoma.